Notably, all these studies demonstrated that stimuli ameliorating/increasing neurogenesis reduce the appearance of AD hallmarks; this suggests the possibility that not only Aβ/pTau affect neurogenesis, but also molecular mechanisms controlling neurogenesis influence Aβ clearance/degradation and/or tau phosphorylation. The gene discussed is MAPT; the disease is Alzheimer disease.